Interestingly, Yoshimura and colleagues have demonstrated that As2O3 sensitizes glioblastoma to a Myc inhibitor-mediated growth inhibition, based on a study using patient-derived glioblastoma cancer stem-like cells and its xenograft model (56). The gene discussed is MYC; the disease is glioblastoma.